サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1678755

乳房病変局在化法の市場規模、シェア、動向分析レポート：タイプ別、地域別、セグメント予測、2025年～2030年

Breast Lesion Localization Methods Market Size, Share & Trends Analysis Report By Type (Wire Guided Localization, Radioisotope Localization, Magnetic Tracer), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
乳房病変局在化法の市場規模、シェア、動向分析レポート：タイプ別、地域別、セグメント予測、2025年～2030年
出版日: 2025年02月13日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

乳房病変局在化法市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の乳房病変局在化法市場規模は2030年までに36億2,000万米ドルに達すると予測され、2025～2030年のCAGRは7.9%で成長すると予測されています。

乳がん診断、生検、検査、関連医療処置に対する政府と非政府の償還施策の増加は、乳房病変局在化法の採用を促進すると予測されています。さらに、女性の乳がん罹患率の上昇を背景とした、医療インフラと施設の改善に対する需要の高まりが、市場成長を後押しすると予測されます。

女性の乳がん罹患率が上昇するにつれて、正確で早期発見法の必要性が高まっています。乳房病変局在化技術は、疑わしい病変を正確に特定し、生検や外科的介入の対象とする上で極めて重要です。例えば、全米乳がん財団（National Breast Cancer Foundation, Inc.）の報告書によると、2024年4月、米国では女性の8人に1人が生涯のうちに乳がんの診断を受けることになります。2024年には、約31万720人の女性と2,800人の男性が浸潤性乳がんと診断されると予測されています。乳がんの有病率の増加に伴い、オーダーメイドの治療戦略に注目が集まっています。先進的な病変局在診断法は、腫瘍医や外科医が綿密な治療計画を立てて治療を実施し、患者の最良の転帰を目指す上で大きな力となります。このような要因が乳房病変局在診断法の需要を押し上げています。

デジタルマンモグラフィ、超音波、MRIなどの画像技術の進歩により、乳房病変の検出と特徴付けが大幅に改善されました。その結果、外科手術を正確に誘導するための正確な局在診断技術に対するニーズが高まっています。さらに、3D画像モダリティとナビゲーションシステムの統合により、外科医は手術中に乳房病変の位置をリアルタイムで視覚化できるようになり、手術精度が大幅に向上して患者の転帰が改善されます。これらの要因が、予測期間中の市場成長を後押ししています。

乳房病変局在化法市場レポートハイライト

  • 製品タイプ別では、ワイヤガイド下定位法が、幅広い製品群の存在とエンドユーザーにおけるこの手法の採用率の高さにより、2024年に最大の市場シェアを占めました。
  • ラジオアイソトープによる乳房局在は、効果的で安全であり、触知不能な疑わしい乳房病変の術前局在診断に広く使用されているため、予測期間中に大きな成長が見込まれます。
  • 北米は、同地域に主要メーカーが存在すること、医療インフラが確立していること、局在化装置の採用率が高いことなどから、2024年の売上高シェアが最も高く、市場を独占しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 乳房病変局在化法の市場変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 乳房病変局在化法市場：タイプ別ビジネス分析

  • タイプ別市場シェア、2024年と2030年
  • タイプセグメントダッシュボード
  • 市場規模と予測と動向分析、タイプ別、2018～2030年
  • ワイヤガイド下定位法
  • 磁気トレーサー
  • その他

第5章 乳房病変局在化法市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 国別、2018～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 国別、2018～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • 国別、2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • BD
    • SOMATEX Medical Technologies GmbH（Hologic Inc.）
    • Argon Medical Devices
    • Merit Medical Systems
    • Cook
    • STERYLAB Srl
    • Theragenics Corporation
    • MDL SRL
    • MOLLI Surgical Inc.（Stryker）
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 5. North America breast lesion localization methods market, by country, 2018 - 2030 (USD Million)
  • Table 6. North America breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 7. U.S. breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 8. Canada breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 9. Mexico breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 10. Europe breast lesion localization methods market, by country, 2018 - 2030 (USD Million)
  • Table 11. Europe breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 12. UK breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 13. Germany breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 14. France breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 15. Italy breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 16. Spain breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 17. Norway breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 18. Denmark breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 19. Sweden breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 20. Asia Pacific breast lesion localization methods market, by country, 2018 - 2030 (USD Million)
  • Table 21. Asia Pacific breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 22. Japan breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 23. China breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 24. India breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 25. Australia breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 26. South Korea breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 27. Thailand breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 28. Latin America breast lesion localization methods market, by country, 2018 - 2030 (USD Million)
  • Table 29. Latin America breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 30. Brazil breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 31. Argentina breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 32. Middle East & Africa Breast lesion localization methods market, by country, 2018 - 2030 (USD Million)
  • Table 33. Middle East & Africa breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 34. South Africa breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 35. Saudi Arabia breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 36. UAE breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 37. Kuwait breast lesion localization methods market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Breast lesion localization methods market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and route of administration outlook (USD Million)
  • Fig. 10 Distribution channel outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Breast lesion localization methods market dynamics
  • Fig. 13 Breast lesion localization methods market: Porter's five forces analysis
  • Fig. 14 Breast lesion localization methods market: PESTLE analysis
  • Fig. 15 Breast lesion localization methods market: Type segment dashboard
  • Fig. 16 Breast lesion localization methods market: Type market share analysis, 2024 & 2030
  • Fig. 17 Wire guided localization market, 2018 - 2030 (USD Million)
  • Fig. 18 Radioisotope localization market, 2018 - 2030 (USD Million)
  • Fig. 19 Radio guided occult-lesion localization (ROLL) market, 2018 - 2030 (USD Million)
  • Fig. 20 Radioactive-seed localization (RSL) market, 2018 - 2030 (USD Million)
  • Fig. 21 Others market, 2018 - 2030 (USD Million)
  • Fig. 22 Magnetic tracer market, 2018 - 2030 (USD Million)
  • Fig. 23 Others market, 2018 - 2030 (USD Million)
  • Fig. 24 Breast lesion localization methods market revenue, by region
  • Fig. 25 Regional marketplace: Key takeaways
  • Fig. 26 Regional marketplace: Key takeaways
  • Fig. 27 North America breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. country dynamics
  • Fig. 29 U.S. breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada country dynamics
  • Fig. 31 Canada breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico country dynamics
  • Fig. 33 Mexico breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 35 UK country dynamics
  • Fig. 36 UK breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany country dynamics
  • Fig. 38 Germany breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 39 France country dynamics
  • Fig. 40 France breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy country dynamics
  • Fig. 42 Italy breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain country dynamics
  • Fig. 44 Spain breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway country dynamics
  • Fig. 46 Norway breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden country dynamics
  • Fig. 48 Sweden breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark country dynamics
  • Fig. 50 Denmark breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan country dynamics
  • Fig. 53 Japan breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 54 China country dynamics
  • Fig. 55 China breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 56 India country dynamics
  • Fig. 57 India breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 58 Australia country dynamics
  • Fig. 59 Australia breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea country dynamics
  • Fig. 61 South Korea breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand country dynamics
  • Fig. 63 Thailand breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil country dynamics
  • Fig. 66 Brazil breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina country dynamics
  • Fig. 68 Argentina breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 69 MEA breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa country dynamics
  • Fig. 71 South Africa breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 72 Saudi Arabia country dynamics
  • Fig. 73 Saudi Arabia breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 74 UAE country dynamics
  • Fig. 75 UAE breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 76 Kuwait country dynamics
  • Fig. 77 Kuwait breast lesion localization methods market, 2018 - 2030 (USD Million)
  • Fig. 78 Company categorization
  • Fig. 79 Company market position analysis
  • Fig. 80 Strategic framework
目次
Product Code: GVR-1-68038-958-6

Breast Lesion Localization Methods Market Growth & Trends:

The global breast lesion localization methods market size is anticipated to reach USD 3.62 billion by 2030 and is anticipated to grow at a CAGR of 7.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing government and non-government reimbursement policies for breast cancer diagnostics, biopsies, examinations, and related medical procedures are projected to drive adoption of breast lesion localization methods. Furthermore, the growing demand for improved healthcare infrastructure and facilities, driven by the rising prevalence of the disease among women, is anticipated to boost the market growth.

As the incidence of breast cancer among women rises, there is a heightened need for precise and early detection methods. Breast lesion localization techniques are pivotal in accurately identifying and targeting suspicious lesions for biopsy or surgical intervention. For instance, As per a report by National Breast Cancer Foundation, Inc., in April 2024, approximately 1 out of every 8 women in the U.S. will receive a breast cancer diagnosis during her lifetime. In 2024, it is projected that around 310,720 women and 2,800 men will be diagnosed with invasive breast cancer. With the increasing prevalence of breast cancer, there is a growing focus on tailored treatment strategies. Advanced lesion localization methods empower oncologists and surgeons to meticulously plan and deliver treatments, aiming for the best possible patient outcomes. These factors are driving the demand for breast lesions localizations methods.

Advancements in imaging technologies like digital mammography, ultrasound, and MRI have greatly improved the detection and characterization of breast lesions. As a result, there is an increased need for precise localization techniques to guide surgical procedures accurately. Furthermore, the integration of 3D imaging modalities and navigation systems allows surgeons to visualize breast lesion locations in real-time during procedures, significantly enhancing surgical precision and improving patient outcomes. These factors are propelling the market growth over the forecast period.

Breast Lesion Localization Methods Market Report Highlights:

  • Based on type, the wire-guided localization segment held the largest market share in 2024 owing to the presence of a wide range of products and high adoption of this technique among end-users.
  • Radioisotope localization is expected to witness significant growth over the forecast period as it is an effective, safe, and widely used procedure for preoperative localization of non-palpable, suspicious breast lesions.
  • North America dominated the market with the highest revenue share in 2024 owing to the presence of key manufacturers in the region, established healthcare infrastructure, and high adoption of localization devices.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Breast Lesion Localization Methods Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Breast Lesion Localization Methods Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Wire Guided Localization
    • 4.4.1. Wire Guided Localization Market, 2018 - 2030 (USD Million)
    • 4.4.2. Radioisotope Localization
      • 4.4.2.1. Radioisotope Localization Market, 2018 - 2030 (USD Million)
    • 4.4.3. Radio Guided Occult-Lesion Localization (ROLL)
      • 4.4.3.1. Radio Guided Occult-Lesion Localization (ROLL) Market, 2018 - 2030 (USD Million)
    • 4.4.4. Radioactive-Seed Localization (RSL)
      • 4.4.4.1. Radioactive-Seed Localization (RSL) Market, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. Magnetic Tracer
    • 4.5.1. Magnetic Tracer Market, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Breast Lesion Localization Methods Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.4.1. North America Breast Lesion Localization Methods Market Estimates And Forecasts, By Country, 2018-2030 (USD Million)
    • 5.4.2. U.S.
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Regulatory Framework
      • 5.4.2.3. Competitive Insights
      • 5.4.2.4. U.S. Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.4.3. Canada
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Regulatory Framework
      • 5.4.3.3. Competitive Insights
      • 5.4.3.4. Canada Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.4.4. Mexico
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Regulatory Framework
      • 5.4.4.3. Competitive Insights
      • 5.4.4.4. Mexico Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. Europe Breast Lesion Localization Methods Market Estimates And Forecasts, By Country, 2018-2030 (USD Million)
    • 5.5.2. UK
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework
      • 5.5.2.3. Competitive Insights
      • 5.5.2.4. UK Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.5.3. Germany
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework
      • 5.5.3.3. Competitive Insights
      • 5.5.3.4. Germany Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.5.4. France
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework
      • 5.5.4.3. Competitive Insights
      • 5.5.4.4. France Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.5.5. Italy
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework
      • 5.5.5.3. Competitive Insights
      • 5.5.5.4. Italy Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.5.6. Spain
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework
      • 5.5.6.3. Competitive Insights
      • 5.5.6.4. Spain Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.5.7. Norway
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework
      • 5.5.7.3. Competitive Insights
      • 5.5.7.4. Norway Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.5.8. Denmark
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework
      • 5.5.8.3. Competitive Insights
      • 5.5.8.4. Denmark Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.5.9. Sweden
      • 5.5.9.1. Key Country Dynamics
      • 5.5.9.2. Regulatory Framework
      • 5.5.9.3. Competitive Insights
      • 5.5.9.4. Sweden Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific Breast Lesion Localization Methods Market Estimates And Forecasts, By Country, 2018-2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework
      • 5.6.2.3. Competitive Insights
      • 5.6.2.4. Japan Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework
      • 5.6.3.3. Competitive Insights
      • 5.6.3.4. China Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.6.4. India
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework
      • 5.6.4.3. Competitive Insights
      • 5.6.4.4. India Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework
      • 5.6.5.3. Competitive Insights
      • 5.6.5.4. South Korea Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.6.6. Australia
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework
      • 5.6.6.3. Competitive Insights
      • 5.6.6.4. Australia Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.6.7. Thailand
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Framework
      • 5.6.7.3. Competitive Insights
      • 5.6.7.4. Thailand Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America Breast Lesion Localization Methods Market Estimates And Forecasts, By Country, 2018-2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework
      • 5.7.2.3. Competitive Insights
      • 5.7.2.4. Brazil Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework
      • 5.7.3.3. Competitive Insights
      • 5.7.3.4. Argentina Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.8. MEA
    • 5.8.1. MEA Breast Lesion Localization Methods Market Estimates And Forecasts, By Country, 2018-2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework
      • 5.8.2.3. Competitive Insights
      • 5.8.2.4. South Africa Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework
      • 5.8.3.3. Competitive Insights
      • 5.8.3.4. Saudi Arabia Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework
      • 5.8.4.3. Competitive Insights
      • 5.8.4.4. UAE Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework
      • 5.8.5.3. Competitive Insights
      • 5.8.5.4. Kuwait Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. BD
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Product Benchmarking
      • 6.5.1.4. Strategic Initiatives
    • 6.5.2. SOMATEX Medical Technologies GmbH (Hologic Inc.)
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Product Benchmarking
      • 6.5.2.4. Strategic Initiatives
    • 6.5.3. Argon Medical Devices
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Product Benchmarking
      • 6.5.3.4. Strategic Initiatives
    • 6.5.4. Merit Medical Systems
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Product Benchmarking
      • 6.5.4.4. Strategic Initiatives
    • 6.5.5. Cook
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Product Benchmarking
      • 6.5.5.4. Strategic Initiatives
    • 6.5.6. STERYLAB S.r.l.
      • 6.5.6.1. Overview
      • 6.5.6.2. Financial Performance
      • 6.5.6.3. Product Benchmarking
      • 6.5.6.4. Strategic Initiatives
    • 6.5.7. Theragenics Corporation
      • 6.5.7.1. Overview
      • 6.5.7.2. Financial Performance
      • 6.5.7.3. Product Benchmarking
      • 6.5.7.4. Strategic Initiatives
    • 6.5.8. MDL SRL
      • 6.5.8.1. Overview
      • 6.5.8.2. Financial Performance
      • 6.5.8.3. Product Benchmarking
      • 6.5.8.4. Strategic Initiatives
    • 6.5.9. MOLLI Surgical Inc. (Stryker)
      • 6.5.9.1. Overview
      • 6.5.9.2. Financial Performance
      • 6.5.9.3. Product Benchmarking
      • 6.5.9.4. Strategic Initiatives